The Multiple Therapeutic Targets of A20

  • Christiane Ferran

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 809)

Table of contents

  1. Front Matter
    Pages i-xxi
  2. Lynn Verstrepen, Isabelle Carpentier, Rudi Beyaert
    Pages 13-31
  3. Karine Enesa, Paul Evans
    Pages 33-48
  4. Meztli Arguello, Suzanne Paz, Christiane Ferran, Herwig P. Moll, John Hiscott
    Pages 49-64
  5. Cleide Gonçalves da Silva, Darlan Conterno Minussi, Christiane Ferran, Markus Bredel
    Pages 65-81
  6. Fiona C. McGillicuddy, Herwig P. Moll, Samira Farouk, Scott M. Damrauer, Christiane Ferran, Muredach P. Reilly
    Pages 83-101
  7. Gabor Bodonyi-Kovacs, Terry B. Strom, Prabhakar Putheti
    Pages 103-116
  8. Cleide Gonçalves da Silva, Jesus Revuelta Cervantes, Peter Studer, Christiane Ferran
    Pages 117-139
  9. Nathan W. Zammit, Shane T. Grey
    Pages 141-162
  10. Alessandra Mele, Jesus Revuelta Cervantes, Victor Chien, David Friedman, Christiane Ferran
    Pages 163-183
  11. Back Matter
    Pages 185-188

About this book


This book is meant to provide the most current knowledge regarding the mechanisms of action of A20, if its versatile functions and their validation in animal models of human disease and its promise as a diagnostic biomarker and therapeutic target.


NF-KB inhibitory function apoptosis diagnostic biomarker endothelial cells inflammation

Editors and affiliations

  • Christiane Ferran
    • 1
    • 2
  1. 1.Department of Surgery, Division of Vascular and Endovascular SurgeryCenter for Vascular Biology ResearchBostonUSA
  2. 2.The Transplant InstituteBeth Israel Deaconess Medical Center, Harvard Medical SchoolBostonUSA

Bibliographic information